SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Alldridge LC, Bryant CE. 2003. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 290: 93107.
  • Alves VA, Nonogaki S, Cury PM, Wünsch-Filho V, de Carvalho MB, Michaluart-Júnior P, Moyses RA, Curioni OA, Figueiredo DL, Scapulatempo-Neto C, Parra ER, Polachini GM, Silistino-Souza R, Oliani SM, Silva-Júnior WA, Nobrega FG, Tajara EH, Zago MA; Head and Neck Genome Project/GENCAPO. 2008. Annexin A1 subcellular expression in laryngeal squamous cell carcinoma. Histopathology 53: 715727.
  • Cao Y, Li Y, Edelweiss M, Arun B, Rosen D, Resetkova E, Wu Y, Liu J, Sahin A, Albarracin CT. 2008. Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol 16: 530534.
  • Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. 2005. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 241: 2739.
  • de Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. 2000. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 31: 371380.
  • Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, Rodrigo JP. 2004. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164: 7379.
  • Gerke V, Moss SE. 2003. Annexins: from structure to function. Physiol Rev 82: 331371.
  • Hermanek P, Scheibe O, Spiessl, B, Wagner, G. 1987. TNM classification of malignant tumors: the new 1987 edition. Rontgen Blatter 40: 200.
  • Hohenberger P, Gretschel S. 2004. Gastric cancer Lancet 362: 305315.
  • Lu QY, Jin YS, Zhang ZF, Le AD, Heber D, Li FP, Dubinett SM, Rao JY. 2008. Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annexin-I in actin remodeling. Lab Invest 87: 456465.
  • Lin CY, Jeng YM, Chou HY, Hsu HC, Yuan RH, Chiang CP, Kuo MY. 2008. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol 97: 544550
  • Lieto E, Ferraraccio F, Orditura M, Castellano P, Mura AL, Pinto M, Zamboli A, De Vita F, Galizia G. 2008. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Ann Surg Oncol 15: 6979.
  • Moutinho C, Mateus AR, Milanezi F, Carneiro F, Seruca R, Suriano G. 2008. Epidermal growth factor receptor structural alterations in gastric cancer. BMC Cancer 8: 10.
  • Nan Y, Yang S, Tian Y, Zhang W, Zhou B, Bu L, Huo S. 2009. Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy. Med Oncol 26: 215221.
  • Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF, III. 2000. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 60: 62936297.
  • Poller DN, Spendlove I, Baker C, Church R, Ellis IO, Plowman GD, Mayer RJ. 1992. Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas. J Pathol 168: 275280
  • Rhee HJ, Kim GY, Huh JW, Kim SW, Na DS. 2000. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem 267: 32203225.
  • Raynal P, Pollard HB. 1994. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197, 6393.
  • Rondepierre F, Bouchon B, Papon J, Bonnet-Duquennoy M, Kintossou R, Moins N, Maublant J, Madelmont JC, D'Incan M, Degoul F. 2009. Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta 1794: 6169.
  • Rothhut B. 1997. Participation of annexins in protein phosphorylation. Cell Mol Life Sci 53: 522526
  • Siang CH, Tunoda T, Whang YE, Tyson DR, Ornstein DK. 2006. The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 66: 14131424.
  • Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. 2006. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12: 45984604.
  • Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y, Han YL, Chen BS, Wei F, Qian XH, Cai YY, Shen Y, Wu M, Wang MR. 2002. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 21: 66416648.
  • Yi M, Schnitzer JE. 2009. Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci USA 106: 1788617891.
  • Yu G, Wang J, Chen Y, Wang X, Pan J, Li Q, Xie K. 2008. Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis 25: 695702.
  • Zeng ZS, Weiser MR, Kuntz E, Chen CT, Khan SA, Forslund A, Nash GM, Gimbel M, Yamaguchi Y, Culliford AT, IV, D'Alessio M, Barany F, Paty PB. 2008. c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett 265: 258269.
  • Zhu FJ, Wang Y, Zeng S, Fu XY, Wang LB, Cao J. 2009. Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study. OMICS 13: 467476.